Skip to main content
. 2012 Aug 7;206(8):1291–1298. doi: 10.1093/infdis/jis494

Table 2.

Equilibrium Type-specific Human Papillomavirus Prevalences for the 9 Model Scenarios

Parameter Delayed Cross-Immunity (d = 0.1) Delayed Independence (d = 1) Delayed Synergy (d = 1.665)
Immediate cross-immunity (c = 0.1) 0.0152 0.0253 0.0272
Immediate independence (c = 1) 0.0162 0.0258 0.0274
Immediate synergy (c = 1.665) 0.0177 0.0262 0.0277